Amy Stump, MD
Surgery · Glen Burnie, MDNPI 1275669392
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 20 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 12 manufacturers, the largest accounting for just 18.2% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for surgery clinicians in MD, where the typical reported total is $976.
Across 20 payments — averaging $18.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$66
- Seagen Inc.$56
- Johnson & Johnson$53
- Daiichi Sankyo Inc.$43
- Puma Biotechnology, Inc.$30
- GSK$24
- plus $92 from 6 others
What the payments were for
- Food & beverage$363100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 3 | $66 |
| Seagen Inc. | 3 | $56 |
| Johnson & Johnson | 3 | $53 |
| Daiichi Sankyo Inc. | 2 | $43 |
| Puma Biotechnology, Inc. | 2 | $30 |
| GSK | 1 | $24 |
| Genentech USA, Inc. | 1 | $20 |
| Heron Therapeutics, Inc. | 1 | $17 |
| Amgen | 1 | $15 |
| Tactile Systems Technology Inc | 1 | $15 |
| Merck | 1 | $14 |
| Organon | 1 | $12 |
How this compares
$363 in reported general payments places this provider in the 30th percentile of 493 surgery providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 32 | $76 |
Paid to pharmacies, not to this prescriber.
Other surgery in Glen Burnie
- Dorry SegevBaltimore$1.2M
- Thomas SwopeBaltimore$775K
- Alisa CokerBaltimore$702K
- Adrian ParkHagerstown$355K
- Igor BelyanskyAnnapolis$339K
- John LedonneBaltimore$329K
- Emad KandilOwings Mills$247K
- Martin MakaryBaltimore$135K
- Richard LuAnnapolis$116K
- Murtaza DawoodBaltimore$82K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.